TP53 and Merkel cell skin cancer: Preservation of the LT RB binding domain and expression of Small T (ST) ensures continual inactivation of RB and degradation of P53 via ubiquitination by MDM2 respectively, leading to uncontrolled cell cycle, accumulation of mutations and development of MCC.